Project management potion for pharmaceutical firm
To help offset the realities of patent expiration and competition from generic drug makers, global pharmaceutical company Pharmacia wants to streamline its supply chain to stay a step ahead of the marketplace.
The maker of such well-known drugs as Rogaine and Xanax, Pharmacia is deploying The A HREF="http://www.businessengine.com">Business Engine (BEN), according to a recent press release. The solution will be used by Pharmacia’s clinical trials and product development teams to streamline the drug development cycle and to bring innovative compounds to market faster.
According to Geraldine Cruz, an industry analyst at Gartner, “The clinical trial solution market has been flooded with software vendors that primarily target the pains associated with task management and with data collection and management. Business Engine’s approach focuses on providing for the needs of everyone involved in the process with its project-based, services relationship management system.”
Business Engine says Pharmacia will use its solution’s collaborative platform and its services relationship module to eliminate blind spots in its outsourced services supply chain. The collaborative capabilities of the Web-based solution will help expedite the RFP/bid/contract process, and will help manage projects around budgets, milestones, deliverables, risks and issues, while providing a common repository for project-related documents, Business Engine says.
The solution provides a private exchange portal--customizable for each CRO vendor, partner and virtual team member--that acts as a single book of record to ease project coordination and avoid miscommunication.
Companies like Pharmacia can save money by speeding product time-to-market through sharing with their partners a single workspace for project management, risk and issue management and document management, says George Van Ness, president and COO of Business Engine.
Pharmacia was created in April 2000 through the merger of Pharmacia & Upjohn with Monsanto Company and its G.D. Searle unit. It employs 59,000 people worldwide and has research, manufacturing and administrative sales operations in more than 60 countries.